Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 15 | 2024 | 421 | 3.740 |
Why?
|
| Electroencephalography | 23 | 2024 | 749 | 3.060 |
Why?
|
| Epilepsy, Temporal Lobe | 13 | 2024 | 131 | 3.020 |
Why?
|
| Visual Cortex | 12 | 2022 | 255 | 2.110 |
Why?
|
| Neurocysticercosis | 4 | 2021 | 6 | 2.040 |
Why?
|
| Electromyography | 3 | 2024 | 193 | 1.940 |
Why?
|
| Hippocampus | 9 | 2022 | 447 | 1.890 |
Why?
|
| Seizures | 13 | 2023 | 305 | 1.690 |
Why?
|
| Muscle, Skeletal | 4 | 2024 | 465 | 1.410 |
Why?
|
| Laser Therapy | 5 | 2023 | 149 | 1.400 |
Why?
|
| Sleep | 9 | 2022 | 450 | 1.370 |
Why?
|
| Brain Mapping | 9 | 2024 | 564 | 1.260 |
Why?
|
| Calcinosis | 3 | 2021 | 230 | 1.170 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2024 | 187 | 1.090 |
Why?
|
| Flavoproteins | 4 | 2011 | 25 | 1.040 |
Why?
|
| Brain | 11 | 2024 | 2269 | 1.010 |
Why?
|
| Photic Stimulation | 11 | 2019 | 501 | 0.990 |
Why?
|
| Isometric Contraction | 1 | 2024 | 42 | 0.940 |
Why?
|
| Machado-Joseph Disease | 1 | 2023 | 8 | 0.900 |
Why?
|
| Models, Neurological | 4 | 2011 | 409 | 0.830 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2023 | 73 | 0.830 |
Why?
|
| Biomarkers | 4 | 2024 | 1751 | 0.750 |
Why?
|
| Atrophy | 3 | 2021 | 119 | 0.740 |
Why?
|
| Space Perception | 4 | 2008 | 117 | 0.740 |
Why?
|
| Synapses | 4 | 2009 | 274 | 0.690 |
Why?
|
| Anticonvulsants | 3 | 2020 | 125 | 0.660 |
Why?
|
| Cysticercus | 1 | 2018 | 2 | 0.650 |
Why?
|
| Antigens, Helminth | 1 | 2018 | 22 | 0.650 |
Why?
|
| Orientation | 4 | 2008 | 119 | 0.640 |
Why?
|
| Humans | 52 | 2024 | 88835 | 0.610 |
Why?
|
| Frontal Lobe | 1 | 2018 | 131 | 0.600 |
Why?
|
| Scalp | 4 | 2022 | 72 | 0.580 |
Why?
|
| Neural Pathways | 3 | 2010 | 318 | 0.560 |
Why?
|
| Cognition | 1 | 2020 | 579 | 0.520 |
Why?
|
| Female | 32 | 2024 | 45893 | 0.510 |
Why?
|
| Piracetam | 1 | 2015 | 8 | 0.510 |
Why?
|
| Visual Perception | 5 | 2022 | 326 | 0.500 |
Why?
|
| Long QT Syndrome | 1 | 2015 | 36 | 0.500 |
Why?
|
| Neuronal Plasticity | 6 | 2023 | 193 | 0.500 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2014 | 6 | 0.500 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2014 | 8 | 0.490 |
Why?
|
| Visual Pathways | 4 | 2011 | 153 | 0.490 |
Why?
|
| Propylene Glycols | 1 | 2014 | 30 | 0.490 |
Why?
|
| Neurons | 6 | 2011 | 1576 | 0.490 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2014 | 2 | 0.480 |
Why?
|
| Electrocorticography | 4 | 2024 | 45 | 0.480 |
Why?
|
| Sphingosine | 1 | 2014 | 74 | 0.480 |
Why?
|
| Lasers | 3 | 2023 | 107 | 0.470 |
Why?
|
| Epilepsy, Generalized | 3 | 2023 | 40 | 0.470 |
Why?
|
| Cats | 8 | 2011 | 305 | 0.470 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 141 | 0.460 |
Why?
|
| Geniculate Bodies | 2 | 2011 | 140 | 0.460 |
Why?
|
| Action Potentials | 6 | 2024 | 595 | 0.450 |
Why?
|
| Functional Laterality | 4 | 2019 | 200 | 0.440 |
Why?
|
| Aging | 2 | 2016 | 713 | 0.430 |
Why?
|
| Adult | 20 | 2024 | 26437 | 0.420 |
Why?
|
| Hair Cells, Auditory | 4 | 1996 | 23 | 0.420 |
Why?
|
| Male | 27 | 2024 | 42127 | 0.420 |
Why?
|
| Stereotaxic Techniques | 4 | 2024 | 80 | 0.410 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2022 | 27 | 0.410 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2023 | 51 | 0.390 |
Why?
|
| Auditory Cortex | 2 | 2022 | 59 | 0.380 |
Why?
|
| Middle Aged | 20 | 2024 | 25783 | 0.370 |
Why?
|
| Arm | 2 | 2024 | 97 | 0.360 |
Why?
|
| Animals | 24 | 2023 | 27272 | 0.360 |
Why?
|
| Motion Perception | 2 | 2008 | 106 | 0.360 |
Why?
|
| Lennox Gastaut Syndrome | 2 | 2020 | 15 | 0.350 |
Why?
|
| Corpus Callosum | 2 | 2020 | 59 | 0.340 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 975 | 0.340 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 263 | 0.340 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 145 | 0.310 |
Why?
|
| Olfactory Pathways | 1 | 2008 | 23 | 0.310 |
Why?
|
| Young Adult | 11 | 2024 | 6271 | 0.310 |
Why?
|
| Olfactory Bulb | 1 | 2008 | 40 | 0.310 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 79 | 0.300 |
Why?
|
| Odorants | 1 | 2008 | 70 | 0.300 |
Why?
|
| Smell | 1 | 2008 | 111 | 0.290 |
Why?
|
| Dominance, Cerebral | 3 | 2005 | 66 | 0.280 |
Why?
|
| Prone Position | 2 | 2017 | 57 | 0.280 |
Why?
|
| Thalamus | 2 | 2023 | 134 | 0.270 |
Why?
|
| Saccule and Utricle | 2 | 1996 | 19 | 0.260 |
Why?
|
| Presynaptic Terminals | 2 | 1996 | 41 | 0.260 |
Why?
|
| Auditory Perception | 3 | 2022 | 98 | 0.250 |
Why?
|
| Subdural Space | 1 | 2024 | 17 | 0.240 |
Why?
|
| Weight-Bearing | 1 | 2024 | 67 | 0.230 |
Why?
|
| Beauty | 1 | 2023 | 8 | 0.230 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 155 | 0.230 |
Why?
|
| Aged | 9 | 2024 | 19014 | 0.230 |
Why?
|
| Glycine | 1 | 2003 | 94 | 0.220 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 85 | 0.220 |
Why?
|
| Intracranial Pressure | 1 | 2023 | 87 | 0.220 |
Why?
|
| Neural Inhibition | 1 | 2003 | 97 | 0.210 |
Why?
|
| Intracranial Hypertension | 1 | 2023 | 57 | 0.210 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1849 | 0.210 |
Why?
|
| Electrodes | 2 | 2024 | 88 | 0.210 |
Why?
|
| Motor Neurons | 1 | 2024 | 173 | 0.210 |
Why?
|
| Memory Consolidation | 1 | 2022 | 15 | 0.210 |
Why?
|
| Central Nervous System | 1 | 2003 | 153 | 0.210 |
Why?
|
| Fluorescence | 4 | 2011 | 103 | 0.210 |
Why?
|
| Deep Brain Stimulation | 1 | 2023 | 62 | 0.210 |
Why?
|
| Mononeuropathies | 1 | 2022 | 8 | 0.200 |
Why?
|
| Cerebellum | 1 | 2023 | 249 | 0.190 |
Why?
|
| Calcium | 2 | 1996 | 1171 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3441 | 0.190 |
Why?
|
| Death, Sudden | 2 | 2019 | 40 | 0.190 |
Why?
|
| Speech Perception | 1 | 2021 | 71 | 0.190 |
Why?
|
| Reaction Time | 3 | 2007 | 310 | 0.190 |
Why?
|
| Electromagnetic Phenomena | 1 | 2020 | 18 | 0.190 |
Why?
|
| Homeostasis | 1 | 2023 | 412 | 0.180 |
Why?
|
| Entropy | 1 | 2020 | 39 | 0.180 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 42 | 0.180 |
Why?
|
| Computers | 1 | 2020 | 112 | 0.180 |
Why?
|
| Theta Rhythm | 1 | 2020 | 29 | 0.180 |
Why?
|
| Contrast Sensitivity | 1 | 2000 | 70 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2024 | 4255 | 0.180 |
Why?
|
| Embryonic Development | 1 | 2020 | 78 | 0.170 |
Why?
|
| Sleep Apnea, Central | 1 | 2019 | 14 | 0.170 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1999 | 11 | 0.170 |
Why?
|
| Neuronavigation | 1 | 2019 | 22 | 0.170 |
Why?
|
| Fourier Analysis | 2 | 2010 | 126 | 0.170 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2019 | 37 | 0.160 |
Why?
|
| Brain Waves | 1 | 2019 | 32 | 0.160 |
Why?
|
| Implantable Neurostimulators | 1 | 2018 | 12 | 0.160 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 87 | 0.160 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 240 | 0.160 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 11 | 0.150 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 32 | 0.150 |
Why?
|
| Sclerosis | 1 | 2017 | 29 | 0.150 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8960 | 0.150 |
Why?
|
| Encephalitis | 1 | 2018 | 104 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2018 | 116 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2019 | 250 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 265 | 0.140 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 227 | 0.140 |
Why?
|
| Delta Rhythm | 1 | 2016 | 19 | 0.140 |
Why?
|
| Rana catesbeiana | 5 | 1996 | 11 | 0.140 |
Why?
|
| Calcium Channels | 2 | 1996 | 182 | 0.140 |
Why?
|
| Hair Cells, Vestibular | 1 | 1996 | 17 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2016 | 68 | 0.140 |
Why?
|
| POEMS Syndrome | 1 | 2016 | 2 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2347 | 0.140 |
Why?
|
| Primary Dysautonomias | 1 | 2016 | 6 | 0.140 |
Why?
|
| Acoustic Stimulation | 3 | 2022 | 131 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 102 | 0.140 |
Why?
|
| Gastrostomy | 1 | 2016 | 69 | 0.140 |
Why?
|
| Receptors, Presynaptic | 1 | 1996 | 4 | 0.130 |
Why?
|
| Rural Population | 1 | 2016 | 142 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 353 | 0.130 |
Why?
|
| Exocytosis | 1 | 1996 | 108 | 0.130 |
Why?
|
| ERG1 Potassium Channel | 1 | 2015 | 15 | 0.130 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2015 | 27 | 0.130 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2014 | 10 | 0.120 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2014 | 30 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 684 | 0.120 |
Why?
|
| Video Recording | 3 | 2020 | 201 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1175 | 0.120 |
Why?
|
| Point Mutation | 1 | 2015 | 245 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2023 | 8177 | 0.110 |
Why?
|
| Risk Factors | 3 | 2020 | 5447 | 0.110 |
Why?
|
| Mice | 5 | 2012 | 11722 | 0.110 |
Why?
|
| Time Factors | 4 | 2019 | 5311 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2015 | 493 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2009 | 436 | 0.110 |
Why?
|
| Prealbumin | 2 | 2022 | 34 | 0.100 |
Why?
|
| Electrophysiology | 2 | 2008 | 403 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3649 | 0.100 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2012 | 28 | 0.100 |
Why?
|
| Adolescent | 6 | 2020 | 9201 | 0.100 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 996 | 0.100 |
Why?
|
| Potassium Channels | 1 | 1994 | 343 | 0.100 |
Why?
|
| Xanthenes | 3 | 1996 | 23 | 0.100 |
Why?
|
| Heart | 1 | 2015 | 573 | 0.100 |
Why?
|
| Neurophysiological Monitoring | 2 | 2023 | 17 | 0.100 |
Why?
|
| Electrodes, Implanted | 2 | 2024 | 177 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2853 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 1712 | 0.100 |
Why?
|
| Aniline Compounds | 3 | 1996 | 58 | 0.100 |
Why?
|
| Psychophysics | 1 | 2011 | 80 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 73 | 0.100 |
Why?
|
| Neocortex | 1 | 2012 | 96 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1938 | 0.090 |
Why?
|
| Wakefulness | 3 | 2020 | 135 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 428 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2009 | 14 | 0.080 |
Why?
|
| Retinal Ganglion Cells | 1 | 2010 | 69 | 0.080 |
Why?
|
| Temporal Lobe | 2 | 2022 | 176 | 0.080 |
Why?
|
| Valine | 1 | 2009 | 62 | 0.080 |
Why?
|
| Glutamates | 1 | 2009 | 89 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 79 | 0.080 |
Why?
|
| Neuropil | 1 | 2008 | 7 | 0.080 |
Why?
|
| Aldehydes | 1 | 2008 | 19 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2008 | 55 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 396 | 0.080 |
Why?
|
| Retinoscopy | 1 | 2007 | 2 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 524 | 0.070 |
Why?
|
| Child | 2 | 2020 | 7112 | 0.070 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 135 | 0.070 |
Why?
|
| Perception | 1 | 2008 | 178 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 226 | 0.070 |
Why?
|
| Sensory Deprivation | 2 | 2012 | 31 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1086 | 0.070 |
Why?
|
| Linear Models | 1 | 2007 | 421 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2273 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1236 | 0.070 |
Why?
|
| Synaptic Vesicles | 2 | 1996 | 36 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 589 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1066 | 0.060 |
Why?
|
| Time Perception | 1 | 2005 | 24 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3202 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 1996 | 276 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 1996 | 243 | 0.060 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2023 | 9 | 0.060 |
Why?
|
| Vision, Monocular | 2 | 2001 | 15 | 0.050 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2022 | 9 | 0.050 |
Why?
|
| Technetium | 1 | 2022 | 29 | 0.050 |
Why?
|
| Diphosphates | 1 | 2022 | 18 | 0.050 |
Why?
|
| Brain Stem | 1 | 2003 | 167 | 0.050 |
Why?
|
| Spatial Memory | 1 | 2022 | 27 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 4039 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 25 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 581 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1233 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 227 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2022 | 301 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2001 | 23 | 0.050 |
Why?
|
| Mental Recall | 1 | 2022 | 157 | 0.050 |
Why?
|
| Receptor, trkA | 1 | 2001 | 15 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 18 | 0.050 |
Why?
|
| Speech | 1 | 2021 | 85 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 778 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2000 | 83 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2020 | 15 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2023 | 865 | 0.050 |
Why?
|
| Ferrets | 1 | 1999 | 47 | 0.040 |
Why?
|
| Pneumonia | 1 | 2020 | 182 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 320 | 0.040 |
Why?
|
| Polysomnography | 1 | 2018 | 150 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 64 | 0.040 |
Why?
|
| Posture | 1 | 2017 | 124 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 16 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 111 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1996 | 33 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2018 | 268 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1238 | 0.030 |
Why?
|
| Neuropathology | 1 | 2016 | 3 | 0.030 |
Why?
|
| Personality | 1 | 2018 | 134 | 0.030 |
Why?
|
| Ambystoma mexicanum | 1 | 1996 | 14 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2000 | 1096 | 0.030 |
Why?
|
| Membranes | 1 | 1996 | 36 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2016 | 65 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 505 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 312 | 0.030 |
Why?
|
| Rana pipiens | 1 | 1994 | 11 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1994 | 130 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1994 | 144 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2011 | 354 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1994 | 116 | 0.030 |
Why?
|
| Otolithic Membrane | 1 | 1993 | 12 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1533 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 73 | 0.030 |
Why?
|
| Algorithms | 1 | 2000 | 1870 | 0.030 |
Why?
|
| Electroporation | 1 | 2012 | 57 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2750 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1591 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 742 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2012 | 206 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 154 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 4121 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 194 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6757 | 0.020 |
Why?
|
| Nerve Net | 1 | 2011 | 372 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 3002 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2001 | 51 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 6 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 19 | 0.010 |
Why?
|
| Axonal Transport | 1 | 2001 | 31 | 0.010 |
Why?
|
| Blindness | 1 | 2001 | 39 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 199 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1796 | 0.010 |
Why?
|
| Mathematics | 1 | 1993 | 191 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 510 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1993 | 472 | 0.010 |
Why?
|